Home About Us Contact Us

 

Table of Content - Volume 21 Issue 2 - February 2022


 

Comparative study to assess the efficacy of bupivacaine with and without dexmeditomidine in ultrasound guided erector spinae plane block in patients undergoing unilateral breast surgery

 

Priyangadevi S1*, Subbalakshmi Sundaram2, Ragul3

 

1Junior Resident, 2Professor, 3Assistant Professor, Department of Anaesthesiology, Rajah Muthaiah Medical College and Hospital, Annamalai University, Chidambaram, Tamil Nadu, INDIA.

Email: sowmiyadevi123@gmail.com

 

Abstract              Background: Dexmedetomidine a selective α-2 adrenergic agonist has been demonstrated to be safe and efficacious in prolonging the duration of post operative analgesia when added as an adjuvant to local anesthetics in nerve blocks. This study was conducted to assess the efficacy of bupivacaine with and without dexmedetomidine in ultrasound guided Erector spinae plane block in patients undergoing unilateral breast surgeries. Methodology: A prospective randomized double blinded experimental study of forty American Society of Anesthesiologists physical status I and II patients posted for elective unilateral breast surgeries were divided into two groups of twenty each as B group and D group, after satisfying the inclusion criteria. Results: In the present study, demographic data were comparable between both the groups. The duration of analgesia was longer in D group (12.60±2.30 hours) compared to B group (10.72±1.46 hours) and was statistically significant, p<0.05. The mean number of doses of rescue analgesia given in first 24 h was higher in B group (1.50±0.68gms) as compared to the D group (1.05±0.68gms) and was statistically significant, p<0.05. The mean VAS score was higher in B group compared to D group and the difference was statistically significant. Conclusion: This study concludes that patients receiving Bupivacaine with dexmedetomidine in ESP block has prolonged duration of analgesia, lower pain scores, lower total analgesic consumption during first 24 hr. compared to patients receiving plain bupivacaine alone.

Key Words: Dexmedetomidine, Erector spinae Plane block, Brest surgery, ultrasound.

 

INTRODUCTION

Breast surgery is one of the commonest surgeries among female population.1 Among those patients only less than half of the population gets adequate pain control. Inadequate pain control will lead to chronic postoperative pain.2 Ultrasound (US)-guided erector spinae plane block (ESPB) is a newer novel analgesic technique introduced by Forero et al.3. Erector spinae plane block provided good postoperative analgesia in patients undergoing breast surgeries as an alternative to other regional techniques like paravertebral block and thoracic epidural.4,5,6 Plain local anesthetics provide postoperative pain relief for only a short duration, and insertion of catheter may not be a viable solution as most of these surgeries are done on a daycare basis. There has been considerable interest in adding adjuncts to local anesthetics, such as clonidine, epinephrine, dexamethasone, tramadol, and midazolam, to prolong the duration and improve the quality of analgesia and hence provide better postoperative pain relief.7 However, only dexmedetomidine has been evaluated as an adjuvant for postoperative pain relief in Erector spinae plane block. Dexmedetomidine a selective α-2 adrenergic agonist has been demonstrated to be safe and efficacious in prolonging the duration of post operative analgesia when added as an adjuvant to local anesthetics in nerve blocks.8,9The present study was planned to compare the postoperative analgesic efficacy of Dexmedetomidine as an adjuvant combined with Ultrasound guided Erector spinae plane block in patients undergoing unilateral breast surgeries. The primary outcome of the study was to measure the duration of analgesia. The secondary outcome includes VAS score, total amount of analgesic requirement for 24 hours following surgery.

 

METHODOLOGY

Our study was conducted as a randomized experimental double blinded study in patients undergoing unilateral breast surgeries at the department of anesthesiology, Rajah Muthiah Medical College, Annamalai university, Chidambaram, Tamil Nādu.

The study protocol was approved by the ethics committee for human experiments and informed consent was taken from each of the patients. Forty ASA I and II patients aged 18–60 years undergoing unilateral breast surgery under General Anesthesia were assigned to one of the two groups each containing twenty patients.

Group B (Bupivacaine group): patients received 20ml of 0.25% Bupivacaine in ultrasound guided Erector spinae plane block.

Group D (Dexmedetomidine group): patients received 20ml of 0.25% Bupivacaine containing 25 micrograms of dexmedetomidine in ultrasound guided Erector spinae plane block.

Patients who have ASA >III, BMI >35, coagulation abnormalities, local skin infection, patient refusal, patients allergic to any of study medications and patients with any history of long-term opioid intake were excluded from the study. All the patients were given T. Alprazolam0.5mg, T. ranitidine 150 mg orally on the night before surgery. Glycopyrrolate 0.2 mg was given intramuscularly 45min before surgery. On the arrival to operation theatre, monitors like pulse oximeter, NIBP, ECG were attached. Baseline parameters namely BP, heart rate, SPO2 were recorded. An intravenous line was secured.

All patients were preoxygenated with 100 % oxygen for three minutes and were administered 1mcg / kg of fentanyl intravenously. Thiopentone sodium 5mg/kg was used for induction and endotracheal intubation was facilitated with succinylcholine 1–2 mg/kg intravenously. Intraoperative monitoring of heart rate, systolic BP, diastolic BP, SPO2 were done. During surgery, anesthesia is maintained with nitrous oxide 66 % and oxygen 33 %, vecuronium 0.1mg kg as maintenance dose. Fentanyl 0.5 mcg / kg was given every 30 mins during surgery. End-tidal carbon dioxide was maintained at 35–40 mmHg. At the end of the surgery, ondansetron 4 mg was given for prophylaxis against post operative nausea and vomiting. Patients were positioned laterally then under aseptic condition the desired thoracic level of injection is counted from c7 spine downwards. A high frequency linear ultrasound probe is placed in a transverse orientation to identify the transverse process. Once identified, the probe is rotated to the longitudinal orientation to obtain a parasagittal view. The structures seen from above to below include; skin, subcutaneous tissue, trapezius muscle, erector spinae muscle and the tip of the transverse process. The echogenic 22 g needle is inserted in an ‘in plane’ approach from cranial to caudal direction till the needle contacts the transverse process. The correct location of the injection site is confirmed by the spread of saline in the myofascial plane above the transverse process lifting off the erector spinae muscle. Then 20ml of drug is injecting in the space. Residual neuromuscular blockade was reversed with neostigmine 0.05 mg / kg and glycopyrrolate 0.01mg/kg, Extubating was done under thorough suction. Patients were observed in the postoperative period for duration of analgesia from ‘0’ hour which was the time of block for both the groups. Patients were monitored at intervals of 15 min, 30 min, 45 min, 1 h, 4 h, 8 h, 12 h and 24 h from administration of Erector spinae plane block. The pain was quantified on a 10cm visual analog scale (VAS). Time from block administration to time for first request of analgesia was taken as duration of analgesia. At first request for analgesia or when VAS score was more than 4, patient was given Inj.Paracetamol 1gm every 6 hours for 24 hrs. Patients were also monitored for sedation evaluated using (modified Ramsay sedation scale)

STATISTICAL METHODS:

The results obtained from the study were presented in the following section. The data was entered into Microsoft excel 2017. The data was then imported into SPSS (Statistical package for social sciences) version 23 for analysis. Descriptive stastistics and inferential statistics included mean, proportion and percentages. Inferential statistics included unpaired ‘t’ test, chi square test and repeated measures ANOVA.


 

 

 

 

RESULTS

The demographic factors and operative factors were comparable between the two groups.

(Table 1) and were not statistically significant.

Table 1: Demographic factors

Variables

group B

group D

‘p’ value

Age (years)

40.35±12.71

40.95±9.21

0.865

BMI (kg/m2)

27.48±1.71

26.70±1.86

0.175

ASA status I (%)

55%

50%

0.75

ASA status II(%)

45%

50%

 

Duration of surgery(min)

97.50±15.26

99.22±13.79

0.706

BMI – Body Mass Index, ASA-American Society of Anesthesiologist

 

The mean duration of analgesia was longer in D group (12.60±2.30 h) compared to B group (10.72±1.46 h) and was statistically significant, ‘p’ value =0.05 (Table 2) (Fig.1). Total consumption of number of inj. paracetamol doses in first 24h was significantly higher in B group. The mean dose of inj. paracetamol consumed in B group was 1.50±0.68 gm and in D group it was 1.05±0.61gm and was statistically significant, ‘p’ value = 0.05 (Table 2) (fig 2). The mean VAS scores assessed at 4,8,12 hours were similar among both the groups whereas at the end of 24th hour B group had higher VAS score compared to D group. ‘p’ value was significant (p=0.001).

 

Table 2: Duration of analgesia, total consumption of analgesics in 24h and VAS scores

Variables

Group B

Group D

P value

Duration of analgesia

10.72±1.46

12.60±2.30

0.05

Number of rescue analgesics

1.50±0.68

1.05±0.61

0.05

VAS score at 4th hr

1.70±0.97

1.30±1.12

0.239

8th hr

2.35±1.84

2.00±1.37

0.500

12th hr

4.20±1.15

3.65±1.18

0.144

24th hr

5.85±1.08

3.60±1.04

0.001*

Figure 1: Bar graph showing duration of analgesia             Figure 2: Number of rescue analgesics

The hemodynamic parameters – HR, RR, SPO2, SBP, DBP were stable throughout the study.

 


DISCUSSION

Various methods of post operative analgesia have been used in breast surgeries such as opiates, nonsteroidal anti-inflammatory agents, wound infiltration with local anesthetic agents, thoracic epidural, and paravertebral blocks, Serratus anterior block, Pecs I and II block. Erector spinae plane block is one such modality which was first introduced by forero et al. in 2016.3 These blocks are easy, reliable techniques, and are devoid of any sympathetic blockade and consequent adverse hemodynamic effects. In addition, peripheral nerve catheters may be inserted to provide prolonged or continuous analgesia but are associated with drawbacks such as dislocation.10But when a local anesthetic is given as a single shot injection the duration of analgesia may not be sufficient to overcome this researcher have found that adding adjuvant like dexmedetomidine will improve the quality and duration of analgesia.11 dexmedetomidine used in nerve blocks attenuates the bupivacaine-induced acute perineural inflammation.12Thus in this we found that bupivacaine with 25microgram of dexmedetomidine had effective post operative analgesia compared to bupivacaine alone.

Kompal Jain, Vikky Jaiswal, Arun Puri (2017) done a case series of erector spine plane block for various surgeries demonstrated that it has wide applications in pain relief ranging from postoperative acute pain in breast surgeries, thoracotomies, and abdominal surgeries to chronic neuropathic pain. They have experienced that ESP block has easily recognizable son anatomy. There are no structures at risk of needle injury in immediate vicinity, making safer with lesser expertise, and no procedural complications as compared to epidural and paravertebral blocks.

Swati Singh, Gunjan Kumar, Akhileshwar (2018) done Ultrasoundguided erector spinae plane block for postoperative analgesia in modified radical mastectomy: A randomized control study shows an effective block for postoperative analgesia in breast cancer surgery. It decreases postoperative morphine requirement. They observed a decrease in postoperative morphine consumption by 65% which was statistically significant, thus establishing its role for analgesia and postoperative opioid sparing effect.13

Mohamed et al. observed that addition of dexmedetomidine 1 μg/kg to bupivacaine in paravertebral blocks for breast cancer surgery prolonged the duration of effective postoperative analgesia and reduced the requirement of analgesics.14

Shaiqa Manzoor and coworkers15 observed that addition of dexmedetomidine to bupivacaine in PECS block increased the duration of analgesia by 40%.

Medha mohta16 observed that addition of dexmedetomidine prolonged the duration of local anesthetic action in thoracic paravertebral block and reduced the need of rescue anlage

patients undergoing major breast cancer surgery.

Helal et al. observed that addition of dexmedetomidine to bupivacaine in a femoral-sciatic nerve block significantly prolonged the duration of sensory and motor blockade by approximately 40%. Time to first analgesic request was 462.5 ± 54.3 min in bupivacaine group and 807.7 ± 112.9 min in dexmedetomidine group.17

Keplinger et al.18 observed a significant dose-dependent increase in the duration of sensory block with dexmedetomidine. Dexmedetomidine in doses ranging from 20 to 150 μg/kg has been used in peripheral nerve blocks. Higher doses of dexmedetomidine may be associated with higher incidence of bradycardia/sedation. In most studies, dexmedetomidine in fixed dose of 100 μg has been used in peripheral nerve blocks.

Limitation: VAS score was not observed during movement.

 

CONCLUSION

In conclusion dexmedetomidine prolongs the duration and improves the quality of postoperative analgesia when used as an adjuvant to bupivacaine in ultrasound guided Erector spinae plane block with no serious side effects.

 

REFERENCES

  1. Breast cancer statistics, 2013.DeSantis C, Ma J, Bryan L, Jemal A CA Cancer J Clin. 2014 Jan-Feb; 64(1):52-62.[PubMed]
  2. Long-term follow-up of breast cancer survivors with post-mastectomy pain syndrome. Macdonald L, Bruce J, Scott NW, Smith WC, Chambers WA Br J Cancer. 2005 Jan 31; 92(2):225-30 [PubMed]
  3. The Erector Spinae Plane Block: A Novel Analgesic Technique in Thoracic Neuropathic Pain. Forero M, Adhikary SD, Lopez H, Tsui C, Chin K Reg Anesth Pain Med. 2016 Sep-Oct; 41(5):621-7.[PubMed
  4. Erector spinae plane block an effective block for post-operative analgesia in modified radical mastectomy. Singh S, Chowdhary NK Indian J Anaesth. 2018 Feb; 62(2):148-150
  5. Erector Spinae Plane Block for Effective Analgesia after Total Mastectomy with Sentinel or Axillary Lymph Node Dissection: a Report of Three Cases.Kwon WJ, Bang SU, Sun WY J Korean Med Sci. 2018 Nov 5; 33(45):e291.
  6. Ultrasound guided erector spinae plane block reduces postoperative opioid consumption following breast surgery: A randomized controlled study. Gürkan Y, Aksu C, Kuş A, Yörükoğlu UH, Kılıç CT J Clin Anesth. 2018 Nov; 50():65-68. [PubMed]
  7. Additives to local anesthetics for peripheral nerve blockade.Brummett CM, Williams BA Int Anesthesiol Clin. 2011 Fall; 49(4):104-16.
  8. Dexmedetomidine as an adjuvant to local anesthetics in brachial plexus blocks: A meta-analysis of randomized controlled trials. Ping Y, Ye Q, Wang W, Ye P, You Z Medicine (Baltimore). 2017 Jan; 96(4):e5846.
  9. Dexmedetomidine added to levobupivacaine prolongs axillary brachial plexus block Esmaoglu A, Yegenoglu F, Akin A, Turk CY Anesth Analg. 2010 Dec; 111(6):1548-51.
  10. Definitive surgery for breast cancer performed on an outpatient basis.Goodman AA, Mendez AL Arch Surg. 1993 Oct; 128(10):1149-52
  11. Dexmedetomidine as an adjuvant to 0.5% ropivacaine in ultrasound-guided axillary brachial plexus block. Koraki E, Stachtari C, Kapsokalyvas I, Stergiouda Z, Katsanevaki A, Trikoupi A
  12. J Clin Pharm Ther. 2018 Jun; 43(3):348-352.
  1. Addition of clonidine or dexmedetomidine to bupivacaine prolongs caudal analgesia in children. El-Hennawy AM, Abd-Elwahab AM, Abd-Elmaksoud AM, El-Ozairy HS, Boulis SR Br J Anaesth. 2009 Aug; 103(2):268-74.
  2. Singh S, Chowdhary NK. Erector spinae block an effective block for postoperative analgesia in modified radical mastectomy. Indian J Anaesth 2018;62:148-50.
  3. Dexmedetomidine as an adjunctive analgesic with bupivacaine in paravertebral analgesia for breast cancer surgery. Mohamed SA, Fares KM, Mohamed AA, Alieldin NH Pain Physician. 2014 Sep-Oct; 17(5):E589-98.
  4. Comparative study to assess the quality of analgesia of bupivacaine and bupivacaine with dexmedetomidine in ultrasound-guided pectoral nerve block type I and II in breast surgeries. Manzoor S1, Taneja R1, Sood N1, Puri A1, PMID: 30104834, PMCID: PMC6066886
  5.  Efficacy of dexmedetomidine as an adjuvant in paravertebral block in breast cancer surgery Medha Mohta, Bhumika Kalra, Ashok K. Sethi and Navneet Kaur Journal of Anesthesia volume 30, pages252–260 (2016)
  6. Effects of perineural administration of dexmedetomidine in combination with bupivacaine in a femoral-sciatic nerve block.
  7. Helal SM, Eskandr AM, Gaballah KM, Gaarour IS
  8. Saudi J Anaesth. 2016 Jan-Mar; 10(1):18-24.
  9. A pharmacodynamic evaluation of dexmedetomidine as an additive drug to ropivacaine for peripheral nerve blockade: A randomised, triple-blind, controlled study in volunteers. Keplinger M, Marhofer P, Kettner SC, Marhofer D, Kimberger O, Zeitlinger M Eur J Anaesthesiol. 2015 Nov; 32(11):790-6.

 







 


 


 


 



 



 





 



































 








 




 








 

 









Policy for Articles with Open Access
Authors who publish with MedPulse International Journal of Anesthesiology (Print ISSN:2579-0900) (Online ISSN: 2636-4654) agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.